Bach et al v. Amedisys, Inc. et al

3:10-cv-00395

Class Action, Derivative Litigation

December 21, 2017
Firms Get $7.4M In Fees For $44M Medicare Fraud Settlement

Bernstein Litowitz Berger & Grossman LLP and other attorneys will get about $7.4 million in fees for securing a $43.75 million settlement for shareholders who claimed a health care provider and its executives covered up a Medicare fraud scheme that ultimately halved its stock price.
June 16, 2017
Amedisys Pays $44M To End Investors' Medicare Fraud Suit

Amedisys Inc. has agreed to pay $43.75 million to settle a shareholder suit alleging the health care provider and its top executives hid a Medicare fraud scheme that caused its stock prices to drop by half, ending the case after seven years of litigation and a trip to the Fifth Circuit.
August 23, 2016
Amedisys Can't Dodge Investor Suit Over Medicare Fraud

A Louisiana federal judge has ruled that Amedysis Inc. investors can proceed with a trimmed version of their proposed class action alleging the health care provider and its top executives hid a Medicare fraud scheme that caused the price of the company's stock to drop by half.
July 02, 2012
Judge Tosses Medicare Fraud Suit Against Amedisys

A Louisiana federal judge on Thursday granted home health care provider Amedisys Inc.'s motion to dismiss a consolidated class action alleging it and several executives improperly inflated Medicare reimbursements, saying the plaintiffs didn't make a strong case about the purported fraud.